EXOZ (EXoZymes) Beginning Cash Position: $3.04 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EXOZ EXoZymes Inc EXOZ
13 GF Score
Price $4.67
! 2 Warning Signs
View Full Analysis

What is EXoZymes Beginning Cash Position?

EXoZymes EXOZ -0.64% 13 Beginning Cash Position is $3.04 Mil as of Mar. 2026. GuruFocus rates EXOZ with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

EXoZymes's Beginning Cash Position for the quarter that ended in Mar. 2026 was $3.04 Mil.

EXoZymes's quarterly Beginning Cash Position declined from Sep. 2025 ($6.99 Mil) to Dec. 2025 ($5.10 Mil) and declined from Dec. 2025 ($5.10 Mil) to Mar. 2026 ($3.04 Mil).

EXoZymes's annual Beginning Cash Position declined from Dec. 2023 ($0.56 Mil) to Dec. 2024 ($0.07 Mil) but then increased from Dec. 2024 ($0.07 Mil) to Dec. 2025 ($9.72 Mil).


EXoZymes Beginning Cash Position Related Terms


EXoZymes Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for EXoZymes's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EXoZymes Beginning Cash Position Chart

EXoZymes Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
0.14 0.55 0.56 0.07 9.72

EXoZymes Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.72 8.51 6.99 5.10 3.04
EXOZ
13GF Score
EXoZymes Inc EXOZ
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EXoZymes Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $3.04 Mil mean?
EXoZymes (EXOZ) has a Beginning Cash Position of $3.04 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on EXoZymes and its competitors.
Is EXoZymes' Beginning Cash Position too high?
EXoZymes' current Beginning Cash Position is $3.04 Mil. Overall, EXoZymes has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does EXoZymes' Beginning Cash Position compare to ACRV and ANVS?
EXoZymes' Beginning Cash Position of $3.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on EXoZymes and its competitors. EXoZymes's current Beginning Cash Position is $3.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EXoZymes stock overvalued right now?
EXoZymes (EXOZ) has a current Beginning Cash Position of $3.04 Mil. The current Beginning Cash Position is $3.04 Mil. EXoZymes' overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For EXoZymes (EXOZ), the current Beginning Cash Position is $3.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EXoZymes Business Description

Address 750 Royal Oaks Drive, Suite 106, Monrovia, CA, USA, 91016
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
13GF Score

Get the complete analysis for EXOZ

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.67
Price